Ery-ped Suspension
Pricing Report NDC 24338-130-13

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Ery-ped (NDC 24338-130-13) is $6.30724 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 22, 2025.

As a a human prescription drug provided by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), this medication is distributed in a 100 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.30724
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 22, 2025
Billable Units
100 ML
Estimated Package Price
$630.72
Data Status
As of Jan 14, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
24338-130-13
Description
100 mL in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $1.93938 (Effective: Dec 17, 2025)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.75823 to $6.39941 per ML. Over this 11 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.7582 - $6.3994
Market Volatility
263.97% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 22, 2025 $6.30724 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Dec 18, 2024 $6.30724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 20, 2024 $6.30724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Oct 23, 2024 $6.30724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Sep 18, 2024 $6.30724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2020 $6.34430 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 18, 2020 $6.34430 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jun 20, 2018 $6.35260 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jun 20, 2018 $6.35260 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Jun 20, 2018 $6.35260 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Feb 22, 2017 $6.26264 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Feb 22, 2017 $6.26264 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Feb 22, 2017 $6.26264 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jan 05, 2016 $6.39941 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Jan 05, 2016 $6.39941 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Jan 05, 2016 $6.39941 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Jul 01, 2015 $5.87102 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Jul 01, 2015 $5.87102 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Jul 01, 2015 $5.87102 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Feb 03, 2015 $4.81239 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Feb 03, 2015 $4.81239 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Feb 03, 2015 $4.81239 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Sep 03, 2014 $3.34189 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Sep 03, 2014 $3.34189 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Sep 03, 2014 $3.34189 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Feb 28, 2014 $2.46150 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Feb 28, 2014 $2.46150 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Feb 28, 2014 $2.46150 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Oct 01, 2013 $1.75823 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026